Table 2 Baseline CMR parameters

LVEDVi (ml/m²)

118 ± 25

124 ± 31

131 ± 27

0.332

LVESVi (ml/m²)

50 ± 14

56 ± 20

61 ± 19

0.153

LVSVi (ml/m²)

69 ± 14

68 ± 16

70 ± 13

0.85

LVEF (%)

59 ± 5

55 ± 7.8

54 ± 8.1

0.173

Effective forward-LVEF (%)

36 ± 8.3

28 ± 7.6

27 ± 9.8

0.002

1

LVMi (g/m²)

53 ± 13

62 ± 14

63 ± 18

0.063

LA volume indexed (ml/m²)

85 ± 23

94 ± 31

107 ± 36

0.063

MR Rvol (ml)

49 ± 25

66 ± 26

71 ± 29

0.002

1

MR RF (%)

39 ± 13

50 ± 9.7

52 ± 13

0.001

1

RVEDVi (ml/m²)

93 ± 24

94 ± 20

98 ± 17

0.429

RVESVi (ml/m²)

43 ± 12

51 ± 14

54 ± 16

0.034

1

RVSVi (ml/m²)

52 ± 16

43 ± 10

44 ± 9.3

0.033

1

RVEF (%)

54 ± 8

46 ± 6.6

46 ± 9.4

0.002

1

AR Rvol (ml)

3.6 ± 3.8

4.2 ± 2.1

3.4 ± 2.4

0.111

AR RF (%)

4.8 ± 3.9

6.8 ± 3.7

5.8 ± 4.1

0.106

PR Rvol (ml)

2.3 ± 2.2

3.4 ± 3.3

2.5 ± 1.6

0.421

PR RF (%)

2.9 ± 2.2

5.2 ± 5.5

3.9 ± 3.0

0.191

TR Rvol (ml)

12 ± 16

16 ± 15

15 ± 13

0.385

TR RF (%)

13 ± 14

19 ± 18

17 ± 15

0.353

RAAi (cm²/m²)

14 ± 3

15 ± 3.8

15 ± 4.3

0.319

Native T1 (ms)*

1017 ± 33

1029 ± 61

1040 ± 52

0.441

ECV*

27.7 ± 3.4

27.1 ± 3.1

28.5 ± 2.8

0.351

LGE presence**

5 (28%)

10 (37%)

10 (50%)

0.383

 Non-ischaemic

4 (22%)

7 (26%)

9 (45%)

0.546

 Ischaemic

1 (6%)

3 (11%)

1 (5%)

LGE (%)**

1.0 ± 2.0

3.1 ± 4.4

3.5 ± 4.1

0.22

LGE (g)**

1.1 ± 2.3

3.3 ± 4.9

3.9 ± 4.9

0.219